Purchase Order 75N94022P00152
- Not listed
- The National Institute of Child Health and Human Development (NICHD), a civilian agency, awarded a firm-fixed-price purchase order contract worth $24,970.34 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the supply of reagent kits and probes, specifically ACD's proprietary RNAscope technology, to support biomedical research efforts across various NIH institutes. ACD has been a longstanding partner for federal research...
- This contract award is to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation, by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $5,110.00 firm-fixed-price purchase order is for ACD's proprietary RNAscope technology and related products to support biomedical research efforts across various NIH institutes and other federal agencies. ACD's expertise in RNA detection has made it a valuable...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,600.56 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNA scope probes to the NIH campus in Bethesda, Maryland with performance from September 8 through September 16, 2016. As the largest biomedical research agency in the world, the NIH and...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,435 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation, also doing business as Bio-Techne. The contract is for the delivery of RNAscope reagents, kits, and specific probes to support NICHD's research efforts. As the leading federal sponsor of biomedical research, NIH aims to uncover new knowledge that will lead...
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $3,857.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNAscope probes, reagent kits, and related products to support research efforts being conducted at the agency's Bethesda, Maryland campus. As the leading...
- This federal contract award, valued at $10,912.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of reagents and kits, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. Through this firm-fixed-price purchase order, ACD will...
- This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $20,000.00 contract supports ACD's provision of its proprietary RNAscope reagents, kits, probes, and related services to aid various biomedical research efforts across NIH and its institutes, including the National Cancer Institute, National Institute of...
- This $4,960 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company that specializes in RNA detection technologies. The contract is for the provision of reagent kits, which ACD supplies to support biomedical research efforts across various National Institutes of Health (NIH) institutes and other federal agencies. ACD's proprietary RNAscope technology and related...
- This federal contract award, valued at $25,000.00, was issued by the National Institute on Deafness and Other Communication Disorders (NIDCD), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the provision of ACD's proprietary RNAscope reagent kits and probes, which enable visualization and quantification of RNA biomarkers in cells and tissues. This...
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $16,732 firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) for gene expression analysis study services. The contract, which does not have a set-aside designation, will support the agency's research efforts in areas such as cancer, infectious diseases, neuroscience, and genomics. As a molecular diagnostics company specializing in RNA detection technologies, ACD will provide its proprietary RNAscope technology and related products, including custom RNA probes, multiplex fluorescent reagent kits, assay services, and related equipment. This contract is part of ACD's ongoing partnership with various NIH institutes to support cutting-edge biomedical research through the use of its advanced cell diagnostics and molecular pathology solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($1k) | 5/29/24 | |
| Not listed | Not listed | $17.8k | 1/24/22 |